Join Exoma CommunityJoin

NAD+

NAD+ (beta-nicotinamide adenine dinucleotide, oxidized form; CAS 53-84-9): redox coenzyme, co-substrate of sirtuins, PARPs and CD38. Reagent for…

NAD+: Scientific Profile

Publicado el · Actualizado el

NAD+ (beta-nicotinamide adenine dinucleotide, oxidized form; CAS 53-84-9). Pyridine dinucleotide coenzyme and redox cofactor; co-substrate of sirtuins, PARPs and CD38. For research.

NAD+ (Nicotinamide Adenine Dinucleotide in its oxidized form; English name Nicotinamide Adenine Dinucleotide; CAS 53-84-9) is an essential coenzyme present in all living cells. With molecular formula C21H27N7O14P2 and an approximate molecular weight of 663.43 g/mol, it is made up of two nucleotides joined through their phosphate groups: one with an adenine base and the other with nicotinamide. NAD+ is one of the most studied molecules in cellular metabolism because of its central role as an electron carrier and as a substrate for a broad family of regulatory enzymes.

From a biochemical standpoint, NAD+ operates mainly through its NAD+/NADH redox pair. In its oxidized form (NAD+) it accepts a hydride ion to become NADH, and this reversible interconversion is the axis of the oxidation-reduction reactions of intermediary metabolism. The molecule acts as a cofactor in glycolysis, in fatty-acid oxidation, in the tricarboxylic acid cycle (Krebs cycle), and in the mitochondrial electron transport chain, where NADH yields its electrons for ATP synthesis through oxidative phosphorylation. For this reason, the redox state of NAD+ is considered an integrated indicator of the cell's energy state.

Beyond its redox function, NAD+ acts as a consumable substrate for three enzyme families of great interest in research. The sirtuins (SIRT1 to SIRT7) are NAD+-dependent deacetylases and ADP-ribosyltransferases involved in the regulation of gene expression, mitochondrial biogenesis, and responses to metabolic stress. The poly(ADP-ribose) polymerases (PARP) use NAD+ in DNA damage and repair signaling. The enzyme CD38, among other ADP-ribosyl cyclases, consumes NAD+ in the generation of calcium second messengers. Because of this consumption, NAD+ availability is regulated by biosynthesis and salvage pathways from precursors such as nicotinamide, nicotinamide riboside, and nicotinamide mononucleotide.

In the research setting, NAD+ and its precursors are used as tools for studying mitochondrial energy metabolism, sirtuin biology, DNA repair, and cellular aging models, where an age-associated decline in NAD+ levels has been documented in various tissues of experimental models. It is a reference reagent in redox enzyme assays and in the study of the biosynthesis and consumption pathways of the dinucleotide itself.

NAD+ is supplied as a lyophilized powder for reconstitution. Because it is a sensitive molecule, frozen storage protected from light and moisture is recommended, along with reconstitution using the sterile diluent indicated in the protocol just before use, avoiding repeated freeze-thaw cycles. This product is offered exclusively as a research reagent (research use only): it is not intended for the diagnosis, prevention or treatment of any disease, nor for human or veterinary consumption.

Mechanism of action

NAD+ acts as a cofactor and substrate in multiple critical cellular pathways:

Energy metabolism:

  1. Essential cofactor for glycolysis and the Krebs cycle
  2. Electron donor in the mitochondrial transport chain
  3. Required for β-oxidation of fatty acids

Sirtuins (SIRT1-7):

  • NAD+ is an obligatory substrate for deacetylase activity
  • SIRT1: Metabolic regulation, insulin sensitivity
  • SIRT3: Mitochondrial function, oxidative stress
  • SIRT6: DNA repair, telomeres

DNA repair:

  • Substrate for PARP (Poly-ADP-ribose polymerase)
  • Critical for the DNA damage response
  • Maintenance of genomic stability

CD38/CD157:

  • Immune modulation
  • Calcium signaling

Mechanism summary

Redox coenzyme NAD+/NADH that fuels Complex I of the mitochondrial electron transport chain; an obligate co-substrate of sirtuins (SIRT1-7) and PARP1/PARP2 in DNA repair, and a substrate of CD38/CD157. A central carrier of intermediary metabolism.

Clinical Studies (7)

  • NAD+ in aging, metabolism, and neurodegeneration (Verdin E. · Science · 2015) — Comprehensive review of the role of NAD+ in aging and cellular metabolism. PMID 26785480.
  • Nicotinamide Adenine Dinucleotide (NAD+) and Enkephalinase Inhibition (IV1114589NAD) Infusions Significantly Attenuate Psychiatric Burden Sequalae in Substance Use Disorder (SUD) in Fifty Cases (Blum, et al. · Current Psychiatry Research and Reviews · 2022) PMID 36118157.
  • Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review (Gindri, et al. · American Journal of Physiology-Endocrinology and Metabolism · 2024) PMID 37971292.
  • Effect of Nicotinamide Adenine Dinucleotide on Heart Failure Caused by Ischemic Cardiomyopathy: A Randomized, Placebo-Controlled Trial. (Yu X, et al. · Am J Cardiovasc Drugs · 2026) PMID 40954388.
  • A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD. (Grant R, et al. · Front Aging Neurosci · 2019) PMID 31572171.
  • NAD⁺ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence. (Gallagher C, et al. · Ageing Res Rev · 2026) PMID 41655607.
  • CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism. (Camacho-Pereira J, et al. · Cell Metab · 2016) PMID 27304511.

Warnings

NAD+ is a compound exclusively for research use (RUO); the following warnings and handling considerations apply to its use in the laboratory:

  • Recommended gradual doses
  • Models with known hypersensitivity to NAD+ or precursors
  • Pregnant or lactating models (insufficient data)
  • Models under 18 years old
  • Models with active neoplasia (NAD+ may modulate cell proliferation)
  • Models with severe hepatic or renal insufficiency
  • Models with uncontrolled arrhythmias (rapid IV administration)

Technical data

CAS
53-84-9
Molecular formula
C21H27N7O14P2
Molecular weight
663.43 Da
Compound type
coenzyme
Storage
-20 °C liofilizado; 2-8 °C reconstituido
Shelf life (lyophilized)
12 months
Shelf life (reconstituted)
14 days refrigerated
Light-sensitive

Available for research

NAD+ is available as a research reagent (RUO):

Frequently asked questions about NAD+

What is NAD+?

NAD+ (beta-nicotinamide adenine dinucleotide, oxidized form; CAS 53-84-9). Pyridine dinucleotide coenzyme and redox cofactor; co-substrate of sirtuins, PARPs, and CD38.

What is the mechanism of action of NAD+?

Redox coenzyme NAD+/NADH that fuels Complex I of the mitochondrial electron transport chain; an obligate co-substrate of sirtuins (SIRT1-7) and PARP1/PARP2 in DNA repair, and a substrate of CD38/CD157. A central carrier of intermediary metabolism.

What is NAD+ researched for?

In preclinical research, NAD+ is studied mainly in: Electron transport chain; DNA repair (PARP); Sirtuin activation. Material for scientific research use only.

What are the chemical properties of NAD+?

Molecular formula C21H27N7O14P2; molecular weight 663.43 Da; CAS number 53-84-9.

How is NAD+ stored?

Condiciones de conservación: -20 °C liofilizado; 2-8 °C reconstituido; estabilidad liofilizado: 12 meses; una vez reconstituido: 14 días refrigerado; protéjase de la luz.

What routes of administration are studied for NAD+?

The following are described in research models: Intravenous, Subcutaneous, Oral (precursors). Use is exclusively for scientific research.

See also